Ariad's mTOR And The FDA CommitteeSeeking AlphaThe first is sirolimus (Rapamune), developed by Wyeth for the prophylaxis of organ rejection for ≥13 years old patients receiving renal transplants. There has been some off-label use of this drug. Th…
stv.tvCampaigners in bid to change law on organ donation in WalesWalesOnlineA LAST ditch attempt to derail controversial plans to change the law on organ donation in Wales has been launched. Campaigners today presented a small petition at the Senedd, o…
USA TODAYAspirin may stop cancer, tobacco kills and gym-goers are shyUSA TODAYHeart failure clue: People who get dizzy after standing up, due to a drop in blood pressure — a condition called orthostatic hypotension — may be at higher risk for eventua…
Cancer Research UKAnalysis reveals most common Cancer Drugs Fund applicationsCancer Research UKOther drugs that received a high number of applications under the Cancer Drugs Fund included lapatinib (Tyverb), rituximab (MabThera) and everolimus (Afinito…
LABS, Inc. Launches Suite of Next-Generation Test Offerings; Focuses on …MarketWatch (press release)Blood spot and buccal swab Human Leukocyte Antigen (HLA) analysis: a simplified method, requiring lower sample volume, for collecting DNA samples for …
LABS, Inc. Launches Suite of Next-Generation Test Offerings; Focuses on …PR Newswire (press release)Blood spot and buccal swab Human Leukocyte Antigen (HLA) analysis: a simplified method, requiring lower sample volume, for collecting DNA samples for …
Arteriovenous Fistulas May Increase Heart Failure RiskRenal and Urology NewsPre-emptive placement of an arteriovenous fistula (AVF) in pre-dialysis patients with advanced chronic kidney disease (CKD) may increase their risk of congestive heart failure …
Heart Failure Congress 2012 to take place from May 19-22News-Medical.netFour days of scientific sessions will be devoted to the latest advances and controversies in heart failure at this year's Heart Failure Congress 2012. The latest results from d…
Bone-marrow derived MSCs may reduce acute rejection rates in kidney recipientsNews-Medical.net"Antibody-based induction therapy plus calcineurin inhibitors (CNIs) reduce acute rejection rates in kidney recipients; however, opportunistic infections…
Prednisolone recall extendedDispensing Doctors’ AssociationBy Ailsa Colquhoun Teva has extended its recall of prednisolone to 2.5mg and 5mg tablets in pots. This adds to the recall of blister packed prednisolone in December, due to stability concerns. …